文献速递糖尿病

瑞典首次与第二代移民2型糖尿病患者的死亡率:10年全国队列研究

Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study.
PubMed 文献 · Diabetologia · 2020-09-26

该全国性队列研究纳入2006-2012年新发 pharmacologically treated 2型糖尿病患者138,085例,随访至2016年比较首次与第二代移民及本土瑞典人的全因和病因别死亡率。首次移民全因死亡率低于本土瑞典人(HR 0.80),非西方地区尤其低,但第二代移民中父母均出生于国外者死亡率高于本土瑞典人(HR 1.28)。

要点

  • 首次移民2型糖尿病患者全因死亡率低于本土瑞典人(HR 0.80)。
  • 非西方地区出生者死亡率尤其低,中东HR 0.41。
  • 第二代移民父母均国外出生者死亡率高于本土瑞典人(HR 1.28)。

核心结论

  • 首次非西方移民2型糖尿病患者死亡率低于本土瑞典人,但随居留时间延长差距缩小,至第二代移民时消失。
  • 文化适应可能影响移民2型糖尿病患者的全因和病因别死亡率,需进一步研究。

研究设计与样本

  • 全国性队列研究,通过瑞典处方药登记识别2006-2012年新发 pharmacologically treated 2型糖尿病患者。
  • 共纳入138,085例,其中本土瑞典人102,163例(74.0%),首次移民28,819例(20.9%),第二代移民7103例(5.1%)。
  • 随访至2016年12月31日评估全因死亡率,至2012年12月31日评估病因别死亡率,采用Cox回归分析调整年龄、性别、社会经济状况、教育、治疗和地区。

主要发现

  • 首次移民全因死亡率低于本土瑞典人(HR 0.80 [95% CI 0.76, 0.84])。
  • 非西方地区出生者死亡率尤其低:中东0.41 [0.36, 0.47]、亚洲0.53 [0.43, 0.66]、非洲0.47 [0.38, 0.59]、拉丁美洲0.53 [0.42, 0.68]。
  • 移民时年龄越大、在瑞典居留时间越短,全因死亡率越低。
  • 在瑞典居留≤24年的首次移民全因死亡率(0.55 [0.51, 0.60])低于居留>24年者(0.92 [0.87, 0.97])。
  • 第二代移民父母均出生于国外者全因死亡率高于本土瑞典人(HR 1.28 [95% CI 1.05, 1.56])。

临床怎么用

  • 对首次非西方移民2型糖尿病患者,需关注随居留时间延长死亡率优势消失的趋势。
  • 第二代移民父母均国外出生者死亡风险较高,应加强随访管理。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Non-Western immigrants to Europe are at high risk for type 2 diabetes. In this nationwide study including incident cases of type 2 diabetes, the aim was to compare all-cause mortality (ACM) and cause-specific mortality (CSM) rates in first- and second-generation immigrants with native Swedes. METHODS: People living in Sweden diagnosed with new-onset pharmacologically treated type 2 diabetes between 2006 and 2012 were identified through the Swedish Prescribed Drug Register. They were followed until 31 December 2016 for ACM and until 31 December 2012 for CSM. Analyses were adjusted for age at diagnosis, sex, socioeconomic status, education, treatment and region. Associations were assessed using Cox regression analysis. RESULTS: In total, 138,085 individuals were diagnosed with type 2 diabetes between 2006 and 2012 and fulfilled inclusion criteria. Of these, 102,163 (74.0%) were native Swedes, 28,819 (20.9%) were first-generation immigrants and 7103 (5.1%) were second-generation immigrants with either one or both parents born outside Sweden. First-generation immigrants had lower ACM rate (HR 0.80 [95% CI 0.76, 0.84]) compared with native Swedes. The mortality rates were particularly low in people born in non-Western regions (0.46 [0.42, 0.50]; the Middle East, 0.41 [0.36, 0.47]; Asia, 0.53 [0.43, 0.66]; Africa, 0.47 [0.38, 0.59]; and Latin America, 0.53 [0.42, 0.68]). ACM rates decreased with older age at migration and shorter stay in Sweden. Compared with native Swedes, first-generation immigrants with ≤ 24 years in Sweden (0.55 [0.51, 0.60]) displayed lower ACM rates than those spending >24 years in Sweden (0.92 [0.87, 0.97]). Second-generation immigrants did not have better survival rates than native Swedes but rather displayed higher ACM rates for people with both parents born abroad (1.28 [1.05, 1.56]). CONCLUSIONS/INTERPRETATION: In people with type 2 diabetes, the lower mortality rate in first-generation non-Western immigrants compared with native Swedes was reduced over time and was equalised in second-generation immigrants. These findings suggest that acculturation to Western culture may impact ACM and CSM in immigrants with type 2 diabetes but further investigation is needed. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Bennet L, Udumyan R, Östgren CJ, et al. Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study. Diabetologia. 2020. PMID: 32979073. doi:10.1007/s00125-020-05279-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。